Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Clinical overview of sorafenib in breast cancer
Alvaro Moreno-Aspitia
Hematology / Oncology / Cancer Center / Breast Clinic
Research output
:
Contribution to journal
›
Review article
›
peer-review
21
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical overview of sorafenib in breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Sorafenib
100%
Breast Neoplasms
51%
Mitogen-Activated Protein Kinase Kinases
14%
Extracellular Signal-Regulated MAP Kinases
14%
Receptor Protein-Tyrosine Kinases
14%
Growth
13%
Neoplasms
13%
Vascular Endothelial Growth Factor A
11%
Early Diagnosis
10%
Cell Proliferation
8%
Apoptosis
8%
Recurrence
7%
Therapeutics
2%